S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Actinium PharmaceuticalsCorvus PharmaceuticalsCyclerion TherapeuticsXynomic PharmaceuticalsCelyad Oncology
SymbolNYSEAMERICAN:ATNMNASDAQ:CRVSNASDAQ:CYCNOTCMKTS:XYNONASDAQ:CYAD
Price Information
Current Price$8.06$3.48$3.84$2.33$7.63
52 Week RangeBuyBuyN/AN/ABuy
MarketRank™
Overall Score1.51.80.80.31.4
Analysis Score3.53.30.00.03.5
Community Score3.22.52.50.02.7
Dividend Score0.00.00.00.00.0
Ownership Score0.03.31.71.70.0
Earnings & Valuation Score0.60.00.00.00.6
Analyst Ratings
Consensus RecommendationBuyBuyN/AN/ABuy
Consensus Price Target$45.00$8.00N/AN/A$19.00
% Upside from Price Target458.31% upside129.89% upsideN/AN/A149.02% upside
Trade Information
Market Cap$109.51 million$97.66 million$130.41 million$115.69 million$106.38 million
Beta1.231.812.2-1.641.69
Average Volume475,3141,103,958960,0291,03318,444
Sales & Book Value
Annual RevenueN/AN/A$4.51 millionN/A$10,000.00
Price / SalesN/AN/A28.92N/A10,637.75
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.03 per share$2.42 per share$3.56 per share($0.49) per share$3.67 per share
Price / BookN/AN/A1.08N/A2.08
Profitability
Net Income$-21,900,000.00$-46,670,000.00$-123,010,000.00$-25,100,000.00$-32,070,000.00
EPSN/A($1.59)N/AN/A($2.57)
Trailing P/E Ratio0.00N/AN/AN/AN/A
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/A-2,322.42%N/AN/A
Return on Equity (ROE)-77.96%-79.15%-105.55%N/AN/A
Return on Assets (ROA)-64.62%-63.99%-57.77%N/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/A0.08%
Current Ratio10.51%4.38%4.31%N/A2.73%
Quick Ratio10.51%4.38%4.31%N/AN/A
Ownership Information
Institutional Ownership Percentage17.55%60.80%68.17%N/A6.39%
Insider Ownership Percentage1.50%45.12%10.70%86.29%N/A
Miscellaneous
Employees30529427105
Shares Outstanding13.59 million28.06 million33.96 million46.27 million13.94 million
Next Earnings DateN/A3/4/2021 (Estimated)5/3/2021 (Estimated)6/4/2021 (Estimated)3/23/2021 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.